BioSpace News Archive

Vireo Health International, Inc. reported financial results for its first quarter ended March 31, 2019. All currency figures referenced in this release reflect U.S. dollar amounts, unless otherwise noted.

IQ4I Research & Consultancy published a new report on “Cell-Based Assays Global Market – Forecast To 2025".

MEI Pharma, Inc., a late-stage pharmaceutical company focused on advancing new therapies for cancer, announced that Daniel P. Gold, Ph.D., president and chief executive officer, will present at the Jefferies 2019 Global Healthcare Conference on Friday, June 7, 2019 at 1:00 p.m. ET.

Findings related to clinical safety and pharmacodynamic response together with evidence of activity in behavioral model of depression outlined in poster presentation

Goldfinch Bio, Inc. announced that Anthony Johnson, M.D., President and Chief Executive Officer of Goldfinch Bio, will present at the following investor conferences in June:

Coming sharp on the heels of a wave of anti-abortion bills passed in a number of states, Men’s Huddle International, a grassroots men’s organization, is calling on men across America to take responsibility for the roles they play in sponsoring, requiring, encouraging, and in some cases their irresponsibility and/or abuse, which often lead women to have abortions.

The Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com

The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) and AstraZeneca, a global, science-led biopharmaceutical company, are collaborating to seek proposals for improving care processes for patients with unresectable stage III and stage IV non-small cell lung cancer (NSCLC)

Vigeo launches with novel biologics pipeline aimed at reprogramming the tumor immune microenvironment and improving cancer treatment outcomes

Annual survey finds Lundbeck US is first among leading pharmaceutical companies in the eyes of patient groups.